首页> 外文期刊>International Journal of Pharmaceutics >Permutation Test (PT) and Tolerated Difference Test (TDT): Two new, robust and powerful nonparametric tests for statistical comparison of dissolution profiles
【24h】

Permutation Test (PT) and Tolerated Difference Test (TDT): Two new, robust and powerful nonparametric tests for statistical comparison of dissolution profiles

机译:置换测试(PT)和容许差异测试(TDT):两种新的,功能强大的强大非参数测试,用于溶出曲线的统计比较

获取原文
获取原文并翻译 | 示例
           

摘要

The most popular way of comparing oral solid forms of drug formulations from different batches or manufacturers is through dissolution profile comparison. Usually, a similarity factor known as (f2) is employed; However, the level of confidence associated with this method is uncertain and its statistical power is low. In addition, f2 lacks the flexibility needed to perform in special scenarios. In this study two new statistical tests based on nonparametrical Permutation Test theory are described, the Permutation Test (PT), which is very restrictive to confer similarity, and the Tolerated Difference Test (TDT), which has flexible restrictedness to confer similarity, are described and compared to f2. The statistical power and robustness of the tests were analyzed by simulation using the Higuchi, Korsmayer, Peppas and Weibull dissolution models. Several batches of oral solid forms were simulated while varying the velocity of dissolution (from 30 min to 300 min to dissolve 85% of the total content) and the variability within each batch (CV 2-30%). For levels of variability below 10% the new tests exhibited better statistical power than f2 and equal or better robustness than f2. TDT can also be modified to distinguish different levels of similarity and can be employed to obtain customized comparisons for specific drugs. In conclusion, two new methods, more versatile and with a stronger statistical basis than f2, are described and proposed as viable alternatives to that method. Additionally, an optimized time sampling strategy and an experimental design-driven strategy for performing dissolution profile comparisons are described. ? 2012 Elsevier B.V. All rights reserved.
机译:比较来自不同批次或制造商的药物制剂的口服固体形式的最流行方法是通过溶出曲线比较。通常,采用一个相似因子(f2)。但是,与此方法关联的置信度尚不确定,其统计功效也很低。此外,f2缺乏在特殊情况下执行所需的灵活性。在这项研究中,描述了两个基于非参数排列检验理论的新统计检验,描述了对相似性非常严格的排列检验(PT)和对相似性具有灵活限制的容许差异检验(TDT)。并与f2比较。使用Higuchi,Korsmayer,Peppas和Weibull溶出度模型通过仿真分析了测试的统计功效和稳健性。模拟了几批口服固体形式,同时改变了溶解速度(从30分钟到300分钟以溶解总含量的85%)和每批内的变异性(CV为2-30%)。对于低于10%的可变性水平,新测试显示出比f2更好的统计功效,以及比f2更好或更高的鲁棒性。还可以对TDT进行修改以区分不同程度的相似性,并可以将其用于特定药物的定制比较。总之,描述了两种新方法,它们比f2具有更多的通用性和更强的统计基础,是该方法的可行替代方案。此外,还介绍了用于执行溶出曲线比较的优化时间采样策略和实验设计驱动策略。 ? 2012 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号